Novartis is responding to COVID-19 with the safety of our associates and patients we serve as our main concern. At a global level, Novartis is contributing to global research efforts, supporting local communities and ensuring stable supply and price of essential medicines. This information center provides updates, guidance and other resources for Pakistan.
Novartis Pakistan response to COVID-19
Novartis in Pakistan continues to monitor the coronavirus (COVID-19) closely. Our focus is to ensure the health and safety of our people, the healthcare professionals we engage with daily, and to ensure the supply of our medicines to patients.
Coronavirus disease (COVID-19) Global updates
As Novartis continues to closely monitor the coronavirus situation, our primary concern is the health and safety of our associates and patients globally.